Medlive Technology Co., Ltd. (HK:2192) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Medlive Technology Co., Ltd. reports a robust first half with a 40.3% increase in revenue and a 50.2% surge in profits for the six-month period ending June 30, 2024, compared to the previous year. The company’s profit attributable to its owners saw a 48.6% rise, while its adjusted net profit grew by 30.3%. The growth was primarily driven by a significant uptick in precision marketing and corporate solutions, which constitute 92.6% of total revenue.
For further insights into HK:2192 stock, check out TipRanks’ Stock Analysis page.